Categories
Article Clinical trials Mixed Therapies (BNCT + Other Therapies) Phase I Studies Phase II Studies Special Issue (Cancers) Toxicity Year 2023

Neutron Capture Therapy Followed by Image-Guided Intensity-Modulated Radiotherapy for Locally Recurrent Head and Neck Cancer: A Prospective Phase I/II Trial

Cancers; 2023

Categories
Article Review Special Issue (Cancers) Year 2023

A Review of Planned, Ongoing Clinical Studies and Recent Development of BNCT in Mainland of China

Cancers; 2023

Categories
Article Special Issue (Cancers) Year 2023

Perceptions of Canadian Radiation Oncologists, Medical Physicists, and Radiation Trainees about the Feasibility and Need of Boron Neutron Capture Therapy (BNCT) in Canada: A National Survey

Cancers; 2023

Categories
Article Chemistry Nanoparticles Small Boron compounds Special Issue (Cancers) Year 2023

Multi-Functional Boron-Delivery Agents for Boron Neutron Capture Therapy of Cancers

Cancers; 2023

Categories
Article Boron imaging Detectors Physics Special Issue (Cancers) Year 2023

Study of Alternative Imaging Methods for In Vivo Boron Neutron Capture Therapy

Cancers; 2023

Categories
Article Boron Compounds Review Special Issue (Cancers) Year 2023

Optimizing Boron Neutron Capture Therapy (BNCT) to Treat Cancer: An Updated Review on the Latest Developments on Boron Compounds and Strategies

Cancers; 2023

Categories
Article Boron Compounds Review Year 2023

Optimizing Boron Neutron Capture Therapy (BNCT) to Treat Cancer: An Updated Review on the Latest Developments on Boron Compounds and Strategies

Cancers, 2023

Categories
Article Boron imaging Year 2023

Development of a 2-(2-Hydroxyphenyl)-1H-benzimidazole-Based Fluorescence Sensor Targeting Boronic Acids for Versatile Application in Boron Neutron Capture Therapy

Cancers, 2023

Categories
Article Boron Determination In-vitro Studies Radiobiology Year 2021

Cobaltabis(dicarbollide) ([o-COSAN]-) as Multifunctional Chemotherapeutics: A Prospective Application in Boron Neutron Capture Therapy (BNCT) for Glioblastoma

Cancers, 2021

Categories
Article Boron Compounds Chemistry In-vitro Studies In-vivo Studies Radiobiology Year 2020

Sunitinib containing carborane pharmacophore with ability to inhibit tyrosine kinases receptors, FLT3, KIT, and PDGFR-β, exhibits powerful in vivo anti-glioblastoma activity

Cancers, 2020